A-166, a new anti-HER2 antibody-drug conjugate for advanced/metastatic solid tumors: phase I results Nov. 19, 2019
FDA approves Adakveo to reduce vaso-occlusive crises in patients with sickle cell disease Nov. 18, 2019
Phase I trial studies Rocket's hematopoietic cell-based gene therapy for pyruvate kinase deficiency Nov. 18, 2019
RSS